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Background: Bone marrow transplantation is a complex and
often overwhelming experience for patients and their families. The
discharge teaching manual that was being used contained informa-
tion that was minimal and outdated to prepare patients and their
families for recovery after discharge. Inconsistent information was
given to patients among inpatient staff as well as inconsistencies in
education between inpatient and outpatient staff.
Purpose and Objectives: The purpose of this project was to
elaborate and update the extraordinary amount of available infor-
mation for patients and their families into one consistent format. A
discharge teaching pamphlet was developed in order to 1) stan-
dardize information given to patients by nursing staff including
both the inpatient and outpatient settings; 2) provide educational
information below an eighth grade level; and 3) develop an ex-
panded, research-based patient education tool reﬂective of national
standards
Method: The Resource Nurse contacted the CDC, ONS,
IBWA, and three other transplant centers for current practice and
teaching materials. Relevant Barnes-Jewish Hospital policies were
reviewed to verify compliance of educational materials. The gath-
ered information was reviewed by BMT Clinical Nurse Specialists,
Nurse Practitioners, coordinators, pharmacists, social worker and
editorial staff.
Results: The material was published as a professional, colored
pamphlet entitled “Recovery”. All BMT staff was educated to
ensure consistent understanding of information to be provided to
patients. An informal survey of patients who had received “Recov-
ery” found many positive comments from patients and families.
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DEVELOPMENT OF A PEDIATRIC HPC DONOR HISTORY QUESTION-
NAIRE (DHQ)
Halverson, T.L.1 1Children’s Memorial Hospital, Chicago, IL.
Utilizing an adult-oriented donor history questionnaire (DHQ)
to determine donor eligibility for a pediatric donor poses unique
challenges. Questions designed to elicit information about poten-
tial communicable disease risks in adults can be unnecessarily
repetitive or conﬂict with state requirements for pediatric patients.
This has led Children’s Memorial Hospital (CMH) to develop a
pediatric HPC DHQ.
The newly-released (adult) HPC DHQ was developed by an
inter-organizational Donor History Questionnaire-Cellular Ther-
apies Task Force to screen allogeneic hematopoietic progenitor
cell (HPC) donors for communicable disease risk factors in accor-
dance with requirements from the FDA, NMDP, AABB and
FACT. User instructions that accompany the (adult) HPC DHQ
recommend administering the questions without changing the or-
der, wording or content. The (adult) HPC DHQ contains 44
questions; 13 of these questions are related to sexual activity and
sexually transmitted diseases.
In the state of Illinois, children between the ages of 12 and 17
must speciﬁcally authorize release of information pertaining to
sexually transmitted diseases and other “highly conﬁdential” health
information. Therefore, DHQ questions relating to sexually trans-
mitted diseases need to be asked while the parents are not present,
and afﬁrmative responses cannot be shared with the parents / legal
guardians without express written authorization by the 12 to 17
year old child. The order of questions in the newly-released HPC
DHQ hinders separate administration of those questions and thus
compliance with state regulations.
An informal survey of other pediatric transplant facilities across
the United States found signiﬁcant variation in the way that DHQs
were administered to potential pediatric donors. Some institutions
administered each DHQ question to the potential donor’s parents,
while others glossed over or omitted questions relating to sexual
activity when they did not seem relevant. Several respondents
noted the need for a pediatric-oriented HPC DHQ.
To fulﬁll the FDA’s requirement for proper determination of
donor eligibility and adhere to state requirements regarding shar-
ing of “highly conﬁdential” health information in adolescent pa-
tients, CMH’s Stem Cell Transplant Program developed and is
currently adopting a pediatric HPC DHQ that streamlines the
interview process while appropriately screening for potential com-
municable disease risks in the pediatric donor.
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A REIMMUNIZATION PROGRAM FOR PEDIATRIC HEMATOPOIETIC PRO-
GENITOR CELL TRANSPLANT (HPCT) RECIPIENTS
Klinger, E.F.1, Daum, C.D.1 1Children’s Hospital of Orange County,
Orange, CA.
“During the ﬁrst 1-4 years after an allogeneic or autologous
HPCT, antibody titers to vaccine-preventable diseases (e.g., teta-
nus, polio, measles) decline if the recipient is not reimmunized.
Despite return of normal neutrophil and lymphocyte counts, hu-
moral and cellular immunity may take as long as one year to fully
recover after HPCT and these diseases can pose increased risk for
HPCT recipients. To acquire the same immunity as others,
HPCT recipients should be routinely reimmunized. The timing of
reimmunization is dependent upon the type of transplant, the type
of immunosuppressive therapy, and whether or not chronic graft
versus host disease has developed.”(CDC guidelines, 2000 and
Avigan et al, 2001) The Children’s Hospital of Orange County
(CHOC) Blood and Marrow Transplant team developed a pro-
gram that addresses the need for reimmunization of the HPCT
recipient population that 1) increases identiﬁcation and evaluation
of HPCT recipients, 2) communicates current CDC recommen-
dations to medical staff, 3) documents vaccinations utilizing exist-
ing organizational and statewide immunization programs, and 4)
improves overall reimmunization implementation . An immuniza-
tion alert for evaluation 1-year post HPCT is posted on the
patient’s chart. Once deemed eligible, the patient elects to receive
the vaccinations at either CHOC or their community-based phy-
sician’s ofﬁce. The primary physician’s ofﬁce receives a 3  5 inch
abbreviated copy of the CDC recommendations attached to the
yellow California “Immunization Record” card and vaccinations
may be documented on any California Immunization Record form.
Patients receiving vaccinations at CHOC utilizes the organiza-
tional immunization record form with the CDC recommendations
printed on the back for reference. The implementation of this
program ensures that HPCT recipients will experience the same
baseline immunity as others as they return to normalcy.
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THE DEVELOPMENT OF A COMPREHENSIVE QUALITY MANAGEMENT
PLAN IN THE BLOOD AND MARROW STEM CELL TRANSPLANT SETTING
Kurosky, A.S.1, DiBiase, R.1, Carolin, K.1 1Karmanos Cancer Institute,
Detroit, MI.
Background: Quality management (QM) is an essential activity
for blood and marrow stem cell transplant (BMT) programs seek-
ing accreditation by the Foundation for Accreditation of Cellular
Therapy (FACT). It is also an area where deﬁciencies are often
observed by FACT inspectors. The components of a health care
quality management plan (QMP) include the development of a
model for health care improvement that promotes best practice
standards, utilizes these practice standards to guide the manage-
ment of patient care, measures outcomes, and improves critical
processes and practices based on the analysis of outcomes. Our
BMT program’s QMP satisﬁed regulatory requirements but the
structure lacked translation into substantive outcome analysis and
changes if indicated. A restructure of the plan was initiated to
capture these essential components of QM. FRAMEWORK: Rec-
ognizing that the activities of hematopoietic progenitor cell col-
lection, processing and the clinical care of patients receiving a
transplant are integrated, the BMT program within this National
Cancer Institute designated comprehensive cancer facility devel-
oped a multi-disciplinary QMP. An overview of the design and
implementation of the QMP will be presented including: a) the
organizational structure of the QM committee including the lead-
ership with ﬁnal responsibility for the QMP and the personnel
responsible for execution of key activities; b) identiﬁcation and
development of pertinent policies and procedures in collection,
laboratory and clinical facilities and those shared across the pro-
gram; c) selection of key measures and processes for audit and
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validation in the collection, processing and clinical areas of the
program; d) identiﬁcation of benchmarks or goals for each key
measure/process; e) restructure of regularly occurring forum to
report and discuss QM activities including review and outcome
analysis of aggregate data on selected measures, identiﬁcation of
need for corrective actions and follow-up assessment of corrective
actions; f) mechanism for reporting deviations and complaints; and
g) the process for determining and maintaining competency of
personnel. DISCUSSION: QM activities should not be a regula-
tory exercise but result in meaningful improvement in a program’s
processes and outcomes. A clearly deﬁned and purposefully exe-
cuted QMP involving personnel from across our BMT program
helps to ensure the safety of the recipient and donor and ensure the
highest quality of care.
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ANNUAL BLOOD AND MARROW TRANSPLANT PATIENT CEL-
EBRATRION IGNITES HOPE, STRENGTH AND RECOVERY
Laub, L.M.1 1Siteman Cancer Center, Barnes-Jewish Hospital/Wash-
ington University School of Medicine, St. Louis, MO.
Background and Purpose: A programmatic way of supporting
Hope, Strength and Recovery in Blood and Marrow Transplanta-
tion patients and their families is signiﬁcant in enhancing patient
care. The journey through transplantation and beyond is challeng-
ing for patients and caregivers. They navigate that journey with
strength, determination and with courage. In order to honor pa-
tients and families an annual patient and family celebration is held
at the Siteman Cancer Center of Barnes-Jewish Hospital.
Objectives: An annual event uniting patients who have been
transplanted only one or two months ago with those who where
transplanted 5, 10, or 20years ago can ignite hope and continued
recovery. The event is not only signiﬁcant for patients and families;
it is also signiﬁcant for the clinical physicians and team members
who provide the care by honoring their passion and commitment
to excellence.
Method: Post transplant patients and families, the referring
physician community, and clinical members of the inpatient and
outpatient BMT team are invited to the annual event. The event is
held at the Ritz Carlton where the atmosphere is truly spectacular.
The division chief addresses the audience at the start of the event
to recognize and honor the guests. Two transplant patients are
asked to speak at the event where they reﬂect back on their journey
and create inspiration. At the end of the evening, the celebration
unites an unrelated recipient with their donor for the very ﬁrst
time. This union captures the spirit of the night and the essence of
the journey that each patient takes.
Results: For the last 13 years the BMT division has held an
annual event to honor patients and family members. The celebra-
tion grew out of the monthly support group and blossomed into a
remarkable evening with over 500 in attendance each year. The
event allows the BMT program to reach out to patients and
families, to referring physicians, to the local community in an
effort to raise transplant awareness, and to the clinical team mem-
bers of the transplant service. The patient celebration brings joy
and enthusiasm, hugs and handshakes and ignites hope, strength
and recovery in all who attend.
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AN EXPLORATIVE QUALITATIVE PILOT STUDY OF HOW PARENTS AND
CHILDREN EXPERIENCE THE TREATMENT WITH ALLOGENEIC STEM
CELL TRANSPLANTAITON (SCT) FOCUSING ON IMPROVEMENT OF
NURSING CARE
Laursen, H.B.1, Heilman, C.2 1Rigshospitalet, BMT-Unit 4042,
Copenhagen, Denmark; 2Rigshospitalet, JMC Paed Clinic II, 4064,
Copenhagen, Denmark.
Purpose: To examine what kind of psychological difﬁculties
Danish parents and children experiens during inpatient treatment
with allogeneic stem cell transplantation.
Methods: Semi-structured qualitative interviews with 6 mothers,
2 fathers and 3 children (age 11-15 years), representing the expe-
rience from seven SCT courses. Seven children were diagnosed
with 3 SAA, 2 ALL and 2 with immune deﬁciency disease. Time
from SCT to the interview was three months to 3frax;1;2 year
(average one year).
Results: The parents described interaction problems in relation
to 1. each other 2. the child undergoing SCT 3. other children in
the family and 4. the nursing staff. The main problems were:
- Lack of continuity in relation to the nursing staff, resulting in
inconsistant information and conﬂicts between children, parents
and nursing staff. It raises emotions such as insecurity, nervousness
and uncertainty.
- Conﬂicts between child and parents related to nursing e.g.
administration of medicine and meeting the child’s needs for food
and liquid. This may raise feelings of frustration and powerlessness
in the parents.
- The feeling of isolation by the parents due to spending most of
their time with the child in a LAF isolation room during the 5-7
weeks transplant course. The feeling of isolation is shown by a
reduction in the parents social life and adult contact. This results in
1. an inappropriate focusing on the child’s well being e.g. lab
results 2. inability to exercise 3. the inability to be able to leave the
child’s room.
- Those parents, who have more than one child, have a feeling of
being divided between the SCT child’s needs and the needs of the
other children in the family.
Conclusion: the parents’ wish to have: 1. a nursing team 2.
consistant information 3. help to handle and solve conﬂicts 4. the
possibility to leave the isolation room 5. the ability to exercise and
6. focus on the entire families situation and not only the SCT
childs problems.
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HEALTH, PERFORMANCE AND PSYCHOSOCIAL ADJUSTMENT OF
HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN TEENAGERS
Lee, J.H.1, Kim, K.S.1, Choi, S.E.1, Bok, G.N.1, Lee, S.Y.1 1St. Mary’s
Hospital Catholic HSCT Center, Seoul, Korea.
This study invesgated health , performance and psychosoical
adjustment of post Haematopoetic Stem Cell Transplantation(H-
SCT) in teenagers for using basal data of rehabilitation and return
to normal life after HSCT. Most of pediatric patients are suffering
from a high degree of depression, anxiety and lowered self-esteem
due to painful invasive treatment for high dose chemotherapy,
radiation therapy and admission. HSCT Survivors have experi-
enced physical weakness, loneliness and isolation as well as physical
symptoms. Especially, the psychosocial aspect of children after
HSCT is very important in health, performance and psychosocial
adjustment.
We studied 63 teenagers who are 12-17 years old at least 100
days after HSCT. We used Nine symptom checklist of EORTC
(European Organization for Research and Treatment of cancer
Therapy) QOL-C30; fatigue, nausea and vomiting, pain, dyspnea,
insomnia, loss of appetite, constipation, diarrhea and ﬁnancial
difﬁculties, Lansky scale (Physical performance) and K-CBCL
(Korea-child behavior Checklist); Social competence scale, Behav-
ior problem scale.
The general characteristics were male 38 (60.3%), female 25
(39.7%), and median age 14.1years old( SD 1.53) .The diagnosis
were AML 23 (36.5%), ALL 18 (28.6%) and SAA 16(25.4%). The
type of transplantation were sibling allogeneic SCT 30 (47.6%),
unrelated SCT 25 (39.7%), autologous SCT 3 (4.8%), Cord 2
(3.1%) and FMM 3(4.8%). In Nine symptom checklist of EORTC,
fatigue (31.7) was the highest and then ﬁnancial difﬁculties (27.1)
and poor appetites (8.5). Eighty to one hundred Lansky score
which is the performance status scale was 53(91.4%). When both
of teenagers compare with standard group, their studying compe-
tence is lower but their socialization and total social competence
are comparatively high.
In conclusion, the major health problems of teenagers(12-17
years old) were fatigue and ﬁnancial difﬁculties after HSCT. How-
ever, the physical performance competence was affected to main-
tain active life. The psychosocial adjustment was high males and
females. However, the total behavior problem scale of females was
very high. We suggest focus on health and psychosocial issues of
teenagers and need to nursing intervention for them.
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